Submitted by Anonymous (not verified) on 12 December 2025 - 12:30
Human medicines European public assessment report (EPAR): Prevymis, letermovir, Date of authorisation: 08/01/2018, Revision: 18, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Prevymis, letermovir, Date of authorisation: 08/01/2018, Revision: 18, Status: Authorised